TY - JOUR
TI - Novel treatment planning approaches to enhance the therapeutic ratio: targeting the molecular mechanisms of radiation therapy
AU - Protopapa, M.
AU - Kouloulias, V.
AU - Kougioumtzopoulou, A.
AU - Liakouli, Z.
AU - Papadimitriou, C.
AU - Zygogianni, A.
JO - Clinical and Translational Oncology
PY - 2020
VL - 22
TODO - 4
SP - 447-456
PB - Springer-Verlag
SN - 1699-048X, 1699-3055
TODO - 10.1007/s12094-019-02165-0
TODO - angiogenesis;  bystander effect;  clinical trial (topic);  controlled study;  human;  immunomodulation;  immunotherapy;  radiotherapy;  review;  therapeutic index;  treatment planning;  bystander effect;  DNA damage;  immunomodulation;  lymph node;  metabolism;  procedures;  radiation response;  radiotherapy planning system, reactive oxygen metabolite, Bystander Effect;  DNA Damage;  Dose Fractionation, Radiation;  Humans;  Immunomodulation;  Lymph Nodes;  Radiotherapy Planning, Computer-Assisted;  Reactive Oxygen Species
TODO - Radiation acts not only through cell death but has also angiogenic, immunomodulatory and bystander effects. The realization of its systemic implications has led to extensive research on the combination of radiotherapy with systemic treatments, including immunotherapy and antiangiogenic agents. Parameters such as dose, fractionation and sequencing of treatments are key determinants of the outcome. However, recent high-quality research indicates that these are not the only radiation therapy parameters that influence its systemic effect. To effectively integrate systemic agents with radiation therapy, these new aspects of radiation therapy planning will have to be taken into consideration in future clinical trials. Our aim is to review these new treatment planning parameters that can influence the balance between contradicting effects of radiation therapy so as to enhance the therapeutic ratio. © 2019, Federación de Sociedades Españolas de Oncología (FESEO).
ER -